11 results
TNF-Alpha Inhibitors Pharmacology
TNF-a receptor activation produces a nunber of effects that can worsen rheumatoid arthritis (RA).
Infliximab is a ... that works like Infliximab ... #TNFAlpha #Inhibitors ... #Pharmacology #Infliximab
TNF-alpha Inhibitors

Dr. Ann Marie Kumfer @AnnKumfer

#TNFalpha #Inhibitors #Diagnosis #Differential #Indications
@AnnKumfer #TNFalpha
Infections in Patients on TNF-alpha Inhibitors - Differential Diagnosis
 • Viral: VZV, Hep B, Hep C,
BrighamChiefs #TNFalpha
Microscopic Colitis - Management Algorithm
Induction: Budesonide 9 mg daily, 6 to 8 weeks
Maintenance: Budesonide low-dose (3-6
combination) adalimumab, infliximab
JAK Inhibitors in 2019

Role in the therapeutic strategy in 2019
 • RA: 2nd line after failure
methotrexate + anti-TNFapha
Rheumatoid Arthritis Summary
Overview: chronic, inflammatory symmetric polyarthritis involving small joints of hands/feet, knees, shoulders
Signs & Symptoms:
Adalimumab, Etanercept, Infliximab
Infliximab Loss-of Response (LOR) in Ulcerative Colitis

by Dr. Waseem Ahmed @Waseem_AhmedMD

#LOR #Infliximab #algorithm #Ulcerative #Colitis #UC
Infliximab Loss-of ... Waseem_AhmedMD #LOR #Infliximab
IBD Therapeutic Drug Monitoring Thresholds
 - Infliximab > 7 mcg/ml
 - Adalimumab > 8 mcg/ml
 -
Thresholds - Infliximab
Neurosarcoidosis - Diagnosis and Treatment
 • 5 to 40% of sarcoidosis, Heterogeneous, often inaugural
 • Central
TNF-a blockers: Infliximab
Rheumatology Guidance - Indications for 3rd Dose (Booster) COVID-19 Vaccines | 8.19.21
Am I eligible for a
Golimumab (Simponi), Infliximab